|
|
|
|
Making the most of cardiac rehabilitation
Cardiac rehabilitation takes on increasing importance as evidence of benefit mounts, the spectrum of target patient populations expands, and the scope of rehabilitation broadens.
|
| |
More>>
|
|
|
|
|
|
Diuretics: Still first-line therapy for hypertension?
A revolution in the pharmacologic treatment of hypertension is under way, according to experts reporting at a conference called "The State of the Hypertension Nation," held recently in New York City. Here are some highlights from the conference.
|
| |
More>>
|
|
|
|
|
|
Research finds drugs cut cardiac risk for diabetics
Insulin sensitizers are poised to become standard medications to reduce the risk of coronary events in patients with Type 2 diabetes, said researchers at the American Heart Association's Scientific Sessions 2005, held recently in Dallas.
|
| |
More>>
|
|
|
|
|
|
A review of antithrombotic therapies in acute coronary syndrome: Should unfractionated heparin be replaced?
Cardiovascular disease afflicts more than 71.3 million people in the United States and accounts for more deaths annually than any other cause. The estimated direct and indirect costs associated with cardiovascular disease in 2006 ($403 billion) were more than double the costs associated with cancer ($190 billion), which is the second-leading cause of death in the United States.
|
| |
More>>
|
|
|
We subscribe to the HONcode principles of the Health On the Net Foundation